Arrowhead Pharmaceuticals
ARWR
#2204
Rank
โ‚ฌ7.78 B
Marketcap
55,29ย โ‚ฌ
Share price
0.54%
Change (1 day)
71.85%
Change (1 year)

EPS for Arrowhead Pharmaceuticals (ARWR)

EPS in 2026 (TTM): -2,88ย โ‚ฌ

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -2,98ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -0,008937ย โ‚ฌ an increase over its 2024 EPS that were of -4,47ย โ‚ฌ.

EPS history for Arrowhead Pharmaceuticals from 1997 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-2,88ย โ‚ฌ32089.59%
2025-0,008937ย โ‚ฌ-99.8%
2024-4,47ย โ‚ฌ161.39%
2023-1,71ย โ‚ฌ17.36%
2022-1,46ย โ‚ฌ19.85%
2021-1,22ย โ‚ฌ61.9%
2020-0,75ย โ‚ฌ-216.67%
20190,64ย โ‚ฌ-210.77%
2018-0,58ย โ‚ฌ38.3%
2017-0,42ย โ‚ฌ-64.93%
2016-1,20ย โ‚ฌ-16.25%
2015-1,43ย โ‚ฌ28%
2014-1,12ย โ‚ฌ-3.85%
2013-1,16ย โ‚ฌ-31.58%
2012-1,70ย โ‚ฌ331.82%
2011-0,39ย โ‚ฌ-51.11%
2010-0,80ย โ‚ฌ-79.07%
2009-3,84ย โ‚ฌ-37.68%
2008-6,17ย โ‚ฌ-16.87%
2007-7,42ย โ‚ฌ38.33%
2006-5,36ย โ‚ฌ122.22%
2005-2,41ย โ‚ฌ42.11%
2004-1,70ย โ‚ฌ533.33%
2003-0,27ย โ‚ฌ-99.08%
2002-29,02ย โ‚ฌ25%
2001-23,21ย โ‚ฌ33.33%
2000-17,41ย โ‚ฌ-121.21%
199982,08ย โ‚ฌ-400%
1998-27,36ย โ‚ฌ-81.48%
1997-147,75ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
7,81ย โ‚ฌ-362.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-7,14ย โ‚ฌ 139.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
8,95ย โ‚ฌ-400.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
4,94ย โ‚ฌ-266.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
-1,64ย โ‚ฌ-45.05%๐Ÿ‡บ๐Ÿ‡ธ USA